LevitasBio, Inc. today introduced the LeviCell ™ SystemEOS, your next-generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells. Using field-proven Levitation Technology, researchers can now effectively scale their experiments up to 16x and process up to 40 million cells per run. The […]
Featured News
Stilla and Promega Announce Co-Marketing Agreement to Offer Complete Digital PCR Workflow Solution
Stilla Technologies , the digital multiplex PCR company and Promega Corporation today announced a co-marketing agreement that will enable sample preparation using the latest Maxwell ® systems and digital PCR (polymerase chain reaction) as part of the six-color naica ® systemcombined. Through this partnership, the companies will provide a streamlined […]
Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals
Cloudera, the hybrid data cloud company, today announced that Japanese pharmaceutical company, Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics capabilities for increased business performance and realize its vision of achieving data-driven innovation. Through this partnership, Shionogi hopes to democratize access to its vast amounts of […]
Castle Biosciences to Acquire AltheaDx
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are focused on mental health. […]
U.S. Physical Therapy Announces Acquisition and Partnership with Chad Madden and Michael Gilbert
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced an acquisition of a six-clinic physical therapy practice in South Central Pennsylvania – Madden and Gilbert Physical Therapy, LLC. Read More
Health Management Associates Acquires Cirdan Health Systems and Consulting
Today, Jay Rosen, founder, president, and co-chairman of Health Management Associates (HMA), announced the firm’s acquisition of Cirdan Health Systems and Consulting (Cirdan). Founded in 2001, Cirdan is a Minnesota-based healthcare consulting and data services firm. A partner to both payers and providers, Cirdan has extensive experience working with health […]
Insud Pharma and Fresenius Kabi combine efforts to accelerate the growth of mAbxience
Insud Pharma announced today that it has entered into an agreement with Fresenius Kabi. Under the terms of the agreement Fresenius Kabi will acquire 55% of mAbxience, the global fully-fledged biotech company of the Spanish group. Read More
THREAD and Amazon Web Services Modernize Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology
THREAD®, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today that it is collaborating with Amazon Web Services, Inc. (AWS) to launch enhancements to the THREAD platform powered by enterprise-scale automation and built-in AI-driven technologies. Read More
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has entered into a definitive agreement to divest Sunosi® (solriamfetol), a dual-acting dopamine and norepinephrine reuptake inhibitor shown to improve wakefulness in adults living with excessive daytime sleepiness (EDS) due to narcolepsy or obstructive sleep apnea (OSA), to Axsome Therapeutics (Nasdaq: […]
Innovent and Lilly Expand Strategic Partnership in Oncology
Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”,NYSE: LLY) today announced that in light of both parties’ shared commitment to continue bringing innovative medicines […]
